Acute leukemias: is MRD already a surrogate for survival?
Adriano Venditti et al. • 17 Feb 2018
Impact of MMRD and ELN genetic classification in outcomes for patients with AML underoging alloHCT
Muhammad Husnain • 17 Feb 2021
Flotetuzumab as salvage therapy for primary induction failure and early AML
Ibrahim Aldoss • 11 Feb 2021